MQS Management’s Mesa Laboratories MLAB Stock Holding History

MQS Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,194	Closed	-$207K	–	567
2025 Q2	$207K	Buy	+2,194	New	+$241K	0.11%	388

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

MQS Management's MLAB Position: Q3 2025 in Review

MQS Management sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 2,194 shares — an estimated $207K sold.

MQS Management first reported a position in MLAB in Q2 2025 and held it in 1 quarter. The position peaked at $207K in Q2 2025. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

MQS Management reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
MQS Management sold 2,194 Mesa Laboratories shares in Q3 2025, an estimated $207K.
MQS Management first reported a position in Mesa Laboratories in Q2 2025 and held it in 1 quarter.
MQS Management's Mesa Laboratories position peaked at $207K in Q2 2025.
141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on MQS Management's 13F filing for Q3 2025, filed 6 Nov 2025.